Aptevo Therapeutics Inc. (APVO) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 171 transactions totaling $42.9M, demonstrating a bullish sentiment with $8.5M in net insider flow. The most recent transaction on Nov 10, 2025 involved a purchase of 13,513 shares valued at $20.1K.
No significant insider buying has been recorded for APVO in the recent period.
No significant insider selling has been recorded for APVO in the recent period.
Based on recent SEC filings, insider sentiment for APVO is bullish with an Insider Alignment Score of 60/100 and a net flow of $8.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Aptevo Therapeutics Inc. (APVO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading APVO stock, having executed 171 transactions in the past 90 days. The most active insider is Capital Partners Lp Tang (Executive), who has made 33 transactions totaling $41.7M.
Get notified when executives and directors at APVO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | Grant Grady III | Executive | Purchase | 13,513 | $1.49 | $20.1K | |
| Aug 8, 2024 | Taylor Daphne | Executive | Option Exercise | 158 | $N/A | $0 | |
| Aug 8, 2024 | G. Lamothe Jeffrey | Executive | Option Exercise | 42 | $N/A | $0 | |
| Aug 8, 2024 | G. Lamothe Jeffrey | Executive | Option Exercise | 272 | $N/A | $0 | |
| Aug 8, 2024 | Kwon Soyoung | Executive | Option Exercise | 213 | $N/A | $0 | |
| Jun 2, 2024 | Grant Grady III | Executive | Option Exercise | 81 | $N/A | $0 | |
| Jun 2, 2024 | Lopez Kunz Barbara | Executive | Option Exercise | 81 | $N/A | $0 | |
| Jun 2, 2024 | Abdun-nabi Daniel | Executive | Option Exercise | 81 | $N/A | $0 | |
| Jun 2, 2024 | Harsanyi Zsolt | Executive | Option Exercise | 81 | $N/A | $0 | |
| Jun 2, 2024 | Niederhuber John | Executive | Option Exercise | 81 | $N/A | $0 | |
| Jun 1, 2024 | Grant Grady III | Executive | Option Exercise | 7 | $N/A | $0 | |
| Jun 1, 2024 | Lopez Kunz Barbara | Executive | Option Exercise | 7 | $N/A | $0 | |
| Jun 1, 2024 | Abdun-nabi Daniel | Executive | Option Exercise | 7 | $N/A | $0 | |
| Jun 1, 2024 | Harsanyi Zsolt | Executive | Option Exercise | 7 | $N/A | $0 | |
| Jun 1, 2024 | Niederhuber John | Executive | Option Exercise | 7 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 41 | $25.7M | 59.7% |
Sale(S) | 18 | $17.2M | 39.9% |
Payment(F) | 21 | $191.8K | 0.4% |
Exercise(M) | 84 | $0 | 0.0% |
Other(J) | 7 | $0 | 0.0% |
Insider activity at Aptevo Therapeutics Inc. shows mixed signals across all time. While $25.7M in purchases indicates some executive confidence,$17.2M in sales balances the picture, resulting in a modest net flow of $8.5M.17 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Capital Partners Lp Tang, has transacted $41.7M during this period.